April 02, 2026 review Reaching new heights? Maximum subcutaneous injection volumes from a technical and clinical development strategy perspective Advanced Drug Delivery Reviews DOI: 10.1016/j.addr.2026.115863 OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 1 References 2 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study 2024 Journal of Clinical Oncology article Medicine Lung Cancer Treatments and Mutations Open access cited by 3 patents 132 citations Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis? 2021 Journal of Pharmaceutical Sciences article Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 7 patents 118 citations 2 results